(Q48187778)

9 February 2018

title

Cytokine producing CD8+ T cells are correlated to MRI features of tissue destruction in MS. (English)

1 reference

9 February 2018

author

Rene van Lier

7

1 reference

9 February 2018

Frederik Barkhof

6

object named as

Frederik Barkhof

1 reference

9 February 2018

1

Joep Killestein

1 reference

9 February 2018

author name string

M Judith Eikelenboom

2

1 reference

9 February 2018

Thijs Izeboud

3

1 reference

9 February 2018

Nynke F Kalkers

4

1 reference

9 February 2018

Herman J Adèr

5

1 reference

9 February 2018

Bernard M J Uitdehaag

8

1 reference

9 February 2018

Chris H Polman

9

1 reference

9 February 2018

publication date

1 September 2003

1 reference

9 February 2018

Journal of Neuroimmunology

published in

1 reference

9 February 2018

volume

142

1 reference

9 February 2018

issue

1-2

1 reference

9 February 2018

page(s)

141-148

1 reference

9 February 2018

Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

A longitudinal MRI study of histopathologically defined hypointense multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

A full genome search in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

Chemokine receptor expression on T cells is related to new lesion development in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

Immune-mediated demyelination

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

Optimizing the association between disability and biological markers in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

TNFalpha production by CD4(+) T cells predicts long-term increase in lesion load on MRI in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

Active MRI lesion appearance in MS patients is preceded by fluctuations in circulating T-helper 1 and 2 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

Cell surface bound and soluble adhesion molecules in CSF and blood in multiple sclerosis: correlation with MRI-measures of subclinical disease severity and activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

Defining the clinical course of multiple sclerosis: Results of an international survey

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

Regulatory T cells control autoimmunity in vivo by inducing apoptotic depletion of activated pathogenic lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

Inflammation in multiple sclerosis: the good, the bad, and the complex

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

1 reference

7 January 2021

An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

Multiple sclerosis: a two-stage disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

Myelin-specific CD8 T cells in the pathogenesis of experimental allergic encephalitis and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

Primary progressive multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

Multiple Sclerosis: Distribution of T Cell Subsets Within Active Chronic Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

Hypointense lesions on T1-weighted spin-echo magnetic resonance imaging: relation to clinical characteristics in subgroups of patients with multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900265-0

7 January 2021

10.1016/S0165-5728(03)00265-0

Identifiers

DOI

1 reference

9 February 2018

PubMed ID

14512173

1 reference

9 February 2018